CLOV logoCLOV
Clover Health Investments Corp

85,690
Loading...
Loading...
News
all
press releases
Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?
Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Zacks·14d ago
News Placeholder
More News
News Placeholder
Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks·15d ago
News Placeholder
Here's Why You Should Add CLOV Stock to Your Portfolio Now
Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.
Zacks·1mo ago
News Placeholder
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks·2mo ago
News Placeholder
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
Zacks·2mo ago
News Placeholder
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.
Zacks·2mo ago
News Placeholder
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Zacks·3mo ago
News Placeholder
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.
Zacks·3mo ago
News Placeholder
Here's Why MOH Shares Are Attracting Prudent Investors Now
Zacks·4mo ago

Latest CLOV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.